/Investor DB

Kurma Partners — 2022 Investments

3 investments dated 2022 · listed companies and verified rows first · show all

DAMAE Medicaldamae-medical.cominSeries A · Feb 2022 · $6M✓ verified

Damae Medical develops deepLive, a non-invasive skin imaging system based on LC-OCT (Line-field Confocal Optical Coherence Tomography) that produces 3D histology-like and confocal-like images of skin tissue.

Deep TechDigital HealthMedical Devices

Anaïs Barut(Co-founder & CEO)inDavid Siret(Co-founder & CTO)inArnaud Dubois(Co-founder & CSO)in

Co-investorsParis-Saclay Seed FundPartech VenturesIdinvest PartnersAgoranovHEC Paris IncubatorCreadev

Germitecgermitec.cominMay 2022 · $12M

Germitec develops UV-C technology-based disinfection systems for high-level decontamination of ultrasound probes and other medical devices used in healthcare settings.

Deep TechHardwareHealthtechMedical DevicesNot stated, FR

Co-investorsEuropean Investment BankEurazeo

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Ermium Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.